| 1. Jiang R, Mei S, Zhao Z.Leucovorin (folinic acid) rescue for high-dose methotrexate: A review.J Clin Pharm Ther.2022.47(9).1452-1460.SCI |
| 2. Cao Li, Shanshan Guo, Jiping Huo, Yiming Gao , Yilong Yan, Zhigang Zhao*.Real-world national trends and socio-economic factors preference of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in China.Frontiers in Endocrinology.2022.13.987081.SCI |
| 3. Zhu B, Yang J, Zhou Z, Ling X, Cheng N, Wang Z, Liu L, Huang X, Song Y, Wang B, Qin X, Zalloua P, Xu XP, Yang L, Zhao Z*. Total bone mineral density is inversely associated with stroke: a family osteoporosis cohort study in rural China.QJM.2022.115(4).228-234.SCI |
| 4. Jiang R, Yang J, Mei S, Zhao Z*.Determination of levodopa by chromatography-based methods in biological samples: a review.Anal Sci.2022.38(8).1009-1017.SCI |
| 5. Li C, Wang Z, Liu S, Guo S, Song Y, Liu L, Zhou Z, Wang B, Huang M, Wang R, Zhai L, Gao Y, Qin X, Wang X, Zheng H, Zhao Z*.Association of Brachial Ankle Pulse Wave Velocity With New Onset Stroke in Hypertensive Patients Aged Less Than 65 With Normal Fasting Glucose Among Chinese Community-Based Population.Front Endocrinol (Lausanne).2022.12.828286.SCI |
| 6. Yan Q, Zhang B, Ling X, Zhu B, Mei S, Yang H, Zhang D, Huo J, Zhao Z*.CTLA-4 Facilitates DNA Damage-Induced Apoptosis by Interacting With PP2A.Front Cell Dev Biol.2022.10.728771.SCI |
| 7. Zhu B, Zhao J, Cao M, Du W, Yang L, Su M, Tian Y, Wu M, Wu T, Wang M, Zhao X, Zhao Z.Predicting 1-Hour Thrombolysis Effect of r-tPA in Patients With Acute Ischemic Stroke Using Machine Learning Algorithm.Front Pharmacol.2022.12.759782.SCI |
| 8. Wu T, Zhang Y, Shi Y, Yu K, Zhao M, Liu S, Zhao Z*.Safety of Glucagon-Like Peptide-1 Receptor Agonists: A Real-World Study Based on the US FDA Adverse Event Reporting System Database.Clin Drug Investig.2022.42(11).965-975.SCI |
| 9. Yang H, Zhang D, Mei S, Zhao Z*.Simultaneous determination of plasma lamotrigine, lamotrigine N2-glucuronide and lamotrigine N2-oxide by UHPLC-MS/MS in epileptic patients.J Pharm Biomed Anal.2022.220.115017.SCI |
| 10. Guan H, Wang C, Chen C, Han S, Zhao Z*.Cost-Effectiveness of 12 First-Line Treatments for Patients With Advanced EGFR Mutated NSCLC in the United Kingdom and China.Front Oncol.2022.12.819674.SCI |
| 11. Zhao Z, Shen J, Shen C, Zhu B, Sun J, Yu J, Sun F, Song H*.An investigation of pharmacovigilance and reporting of adverse drug reactions in hospitals: a cross-sectional study in China.Curr Med Res Opin.2021.37(11).2001-2006.SCI |
| 12. Zhu B, Zhang L, Du W, Yang J, Tian Y, Wu M, Wu T, Ling X, Liu Y, Zhao X*, Zhao Z*.Levels of Fibrin Degradation Products at Admission With Acute Ischemic Stroke Correlate With the NIH Stroke Scale Score 1 h After Intravenous Thrombolysis.Front Neurol.2021.12.651867.SCI |
| 13. Zhu B, Feng X, Jiang C, Mi S, Yang L, Zhao Z, Zhang Y, Zhang L.Correlation between white blood cell count at admission and mortality in COVID-19 patients: a retrospective study.BMC Infect Dis.2021.21(1).574.SCI |
| 14. Zhang Y, Sun L, Zhao L, Wang X, Zhao Z*, Mei S*.Methotrexate Polyglutamates Analysis by Chromatography Methods in Biological Matrices: A Review.Anal Sci.2021.37(12).1655-1664.SCI |
| 15. Li C, Xiao P, Lin D, Zhong HJ, Zhang R, Zhao ZG*, He XX*.Risk Factors for Intestinal Barrier Impairment in Patients With Essential Hypertension.Front Med (Lausanne).2021.7.543698.SCI |
| 16. Cao Li , Shanshan Guo , Wenyuan Pang , Zhigang Zhao*.Crosstalk Between Acid Sphingomyelinase and Inflammasome Signaling and Their Emerging Roles in Tissue Injury and Fibrosis.Front Cell Dev Biol.2020.7.378.SCI |
| 17. Shenghui Mei * , Yong Cui , Dongjie Zhang , Chun Zeng , Xiaohui Ren , Kefu Yu , Song Lin# , Zhigang Zhao#.Simultaneous Determination of Urine Methotrexate, 7-Hydroxy Methotrexate, Deoxyaminopteroic Acid, and 7-Hydroxy Deoxyaminopteroic Acid by UHPLC-MS/MS in Patients Receiving High-dose Methotrexate Therapy.Anal Sci.2020.36(12).1479-1486.SCI |
| 18. Wenyuan Pang * , Qiaoyu Wang , Zhigang Zhao #.Development and progress of clinical trials of Coronavirus Disease 2019 antiviral drugs.Expert Rev Clin Pharmacol.2020.13(9).945-956.SCI |
| 19. Liu X, Men P, Wang B, Cai G, Zhao Z*.Effect of dipeptidyl-peptidase-4 inhibitors on C-reactive protein in patients with type 2 diabetes: a systematic review and meta-analysis..Lipids Health Dis..2019.18(1).144.SCI |
| 20. Zhu B, Gao M, Zhang L, Wang J, Wang L, Qin LL, Kang XX, Zhao ZG*.Association of PTTG1 polymorphism rs1895320, rs2910200 and rs6882742 with non-functioning pituitary adenomas in Chinese Han population: a case-control study..Metab Brain Dis..2019.34(3).841-846.SCI |
| 21. Yang S, Jin H, Zhao ZG.Epidermal growth factor treatment has protective effects on the integrity of the blood-brain barrier against cerebral ischemia injury in bEnd3 cells..Exp Ther Med..2019.17(3).2397-2402.SCI |
| 22. Yang S, Hu J, Li Y, Zhao Z..Evaluation of pharmacokinetic interactions between bicyclol and co-administered drugs in rat and human liver microsomes in vitro and in rats in vivo..Xenobiotica.2019.9(8).987-994.SCI |
| 23. Shanshan Guo,Shenghui Mei,Qiaoyu Wang,Xingang Li,Yang chen,Qiyang He,Zhigang Zhao.Determination of cantharidic acid in rat blood by microdialysis.INTERNATIONAL JOURNAL OF MASS SPECTROMETRY.2019.40.20-26.SCI |
| 24. Gong X,Mei S,Li X,Li X,Zhou H,Liu Y,Zhou A,Yang L,Zhang X,Zhao Z.Association between TPMT*3C and decreased thiopurine S-methyltransferase activity in patients with neuromyelitis optica spectrum disorders in China. .Int J Neurosci. .2018.128(6).549-553..SCI |
| 25. Li X1,Sun S,Wang Q,Zhao Z.Population Pharmacokinetics of Combined Intravenous and Local Intrathecal Administration of Meropenem in Aneurysm Patients with Suspected Intracranial Infections After Craniotomy.Eur J Drug Metab Pharmacokinet.2018.43(1).45-53.SCI |
| 26. Li X,Wu Y,Sun S,Wang Q,Zhao Z.Factors Influencing Norvancomycin Concentration in Plasma and Cerebrospinal Fluid in Patients After Craniotomy and Dosing Guideline: A Population Approach.Clin Ther.2018.40(1).74-82.SCI |
| 27. Yang S,Jin H,Zhao Z.An ECV304 monoculture model for permeability assessment of blood-brain barrier. .Neurol Res. .2018.40(2).117-121. .SCI |
| 28. Zhu B,Li LX,Zhang L,Yang S,Tian Y,Guo SS,Zhao Z,Zhang W.Correlation of PICALM polymorphism rs3851179 with Alzheimer's disease among Caucasian and Chinese populations: a meta-analysis and systematic review. .Metab Brain Dis. .2018.33(6).1849-1857.SCI |
| 29. Mei S,Shi X,Du Y,Cui Y,Zeng C,Ren X,Yu K,Zhao Z,Lin S.Simultaneous determination of plasma methotrexate and 7-hydroxy methotrexate by UHPLC-MS/MS in patients receiving high-dose methotrexate therapy..J Pharm Biomed Anal. .2018.158.300-306.SCI |
| 30. Mei S,Wang J,Chen D,Zhu L,Zhao M,Tian X,Hu X,Zhao Z.Simultaneous determination of cyclosporine and tacrolimus in human whole blood by ultra-high performance liquid chromatography tandem mass spectrometry and comparison with a chemiluminescence microparticle immunoassay..J Chromatogr B Analyt Technol Biomed Life Sci..2018.15.1087-1088:36-42. .SCI |
| 31. Mei S,Li X,Jiang X,Yu K,Lin S,Zhao Z .Population Pharmacokinetics of High-Dose Methotrexate in Patients With Primary Central Nervous System Lymphoma..J Pharm Sci. .2018.107(5).1454-1460.SCI |
| 32. Feng W,Mei S,Zhu L,Yu Y,Yang W,Gao B,Wu X,Zhao Z,Fang F.Effects of UGT2B7,SCN1A and CYP3A4 on the therapeutic response of sodium valproate treatment in children with generalized seizures. .Seizure..2018.58.96-100.SCI |
| 33. Mei S,Wang J,Chen D,Zhu L,Zhao M,Hu X,Yang L,Zhao Z.Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry for Cyclosporine Analysis in Human Whole Blood and Comparison With an Antibody-Conjugated Magnetic Immunoassay. .Ther Drug Monit. .2018.40(1).69-75. .SCI |
| 34. Mei S,Wang J,Cheng Q,Zhu L,Yang L,Chen R,Zhao Z.Development,validation,and application of an UPLC-MS/MS method for norvancomycin analysis in human blood plasma..J Chromatogr B Analyt Technol Biomed Life Sci. .2018.1072.199-204..SCI |
| 35. Mei S,Feng W,Zhu L,Li X,Yu Y,Yang W,Gao B,Wu X,Fang F,Zhao Z.Effect of CYP2C19,UGT1A8,and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model. .Eur J Clin Pharmacol..2018.74(8).1029-1036. .SCI |
| 36. Wang H,Li X,Sun S,Mao G,Xiao P,Fu C,Liang Z,Zheng M,Huang Y,Tang H,Ou R,Yang N,Ling X,Zhao Z.Population Pharmacokinetics and Dosing Simulations of Ceftazidime in Chinese Neonates. .J Pharm Sci..2018.107(5) .1416-1422. .SCI |
| 37. Zhu B,Zhang L,Cheng XP,Wang L,Tian Y,Li XX,Liu YP,Zhao Z.The association between metabolic syndrome and asymptomatic carotid artery stenosis in menopausal women: a cross-sectional study in a Chinese population. .Ther Clin Risk Manag. .2018.14.2183-2188.SCI |
| 38. Yang S,Hu J,Li Y,Zhao Z.CYP2J2 is the major enzyme in human liver microsomes responsible for hydroxylation of SYL-927,a novel and selective sphingosine 1-phosphate receptor 1 (S1P(1) ) agonist. .Biopharm Drug Dispos..2018.39(9).431-436..SCI |
| 39. Yang S,Jin H,Zhao Z.Paracellular tightness and the functional expression of efflux transporters P-gp and BCRP in bEnd3 cells. .Neurol Res. .2018.40(8).644-649. .SCI |
| 40. Huo J,Liu C,Jin BB,Duan FX,Mei SH,Li XG,Zhao Z.Cryptogenic organizing pneumonia masquerading as lung carcinoma: A case report and review of the literature. .Exp Ther Med. .2018.15(1): .39-46. .SCI |
| 41. Li X,Jiang L,Sun S,Li W,Li X,Miao Z,Zhao Z,Ma N.The influence of ABCB1 and P2Y12 genetic variants on clinical outcomes in Chinese intracranial artery stenosis patients. .Clin Exp Pharmacol Physiol. .2018.45.978–982.SCI |
| 42. Li X,Sun S,Wang Q,Zhao Z.Population Pharmacokinetics of Combined Intravenous and Local Intrathecal Administration of Meropenem in Aneurysm Patients with Suspected Intracranial Infections After Craniotomy. .Eur J Drug Metab Pharmacokinet..2018.43(1).45-53.SCI |
| 43. Guo S,Tian J,Zhu B,Yang S,Yu K,Zhao Z.Trends in metabolomics research: a scientometric analysis (1992-2017). .Current Science.2018.114(11).2248-2255.SCI |
| 44. Zhu B,Ming Gao,Lei Zhang,Juan Wang,Lei Wang,Ling Ling Qin,Xi Xiong Kang,Zhao Z.Association of PTTG1 Polymorphism rs1895320,rs2910200 and rs6882742 with Non-functioning Pituitary Adenomas in Chinese Han population: A Case-Control Study,.Metab Brain Dis. .2018.Epub ahead print.Epub ahead print.SCI |
| 45. Yang S,Hu J,Li Y,Zhao Z.Evaluation of pharmacokinetic interactions between bicyclol and co-administered drugs in rat and human liver microsomes in vitro and in rats in vivo. .Xenobiotica. .2018.14.1-27.SCI |
| 46. Li X,Wang X,Wu Y,Sun S,Chen K,Wang Q,Zhao Z.Plasma and cerebrospinal fluid population pharmacokinetic modeling and simulation of meropenem after intravenous and intrathecal administration in postoperative neurosurgical patients .DIAGN MICR INFEC DIS .2018.Epub ahead of print.Epub ahead of print.SCI |
| 47. Wang B, Li XQ, Ma N, Mo D, Gao F, Sun X, Xu X, Liu L, Song L, Li XG, Zhao Z, Zhao X, Miao ZR.Association of thrombelastographic parameters with post-stenting ischemic events.J NEUROINTERV SURG..2017.9(2).192-195.SCI |
| 48. Mei S, Li X, Gong X, Li X, Yang L, Zhou H, Liu Y, Zhou A, Zhu L, Zhang X, Zhao Z..LC-MS/MS Analysis of Erythrocyte Thiopurine Nucleotides and Their Association With Genetic Variants in Patients With Neuromyelitis Optica Spectrum Disorders Taking Azathioprine..Ther Drug Monit. .2017.39(1).5-12.SCI |
| 49. Mei S, Wang J, Zhu L, Chen R, Li X, Chen K, Chen G, Zhou J, Wang Q, Zhao Z..A UPLC-MS/MS method for analysis of vancomycin in human cerebrospinal fluid and comparison with the chemiluminescence immunoassay..Biomed Chromatogr. .2017.doi: 10.1002/bmc.3939..Epub ahead of print.SCI |
| 50. Zhu B, Wang RM, Wang JT, Chen RL, Zheng YF, Zhang L, Zhao ZG..Correlation of rs9331888 polymorphism with Alzheimer's disease among Caucasian and Chinese populations: a meta-analysis and systematic review..Metab Brain Dis..2017.doi: 10.1007/s11011-017-9957-8..Epub ahead of print.SCI |
| 51. Mei S, Li X, Gong X, Zhang X, Li X, Yang L, Zhu L, Zhou H, Liu Y, Zhou A, Zhang X, Zhao Z..Comparison of 6-mercaptopurine with 6-thioguanine for the analysis of thiopurine S-methyltransferase activity in human erythrocyte by LC-MS/MS..Biomed Chromatogr..2017.doi: 10.1002/bmc.3959..Epub ahead of print.SCI |
| 52. Li X1; Zhao Z1;Sun SS.Association of human leukocyte antigen variants and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A meta-analysis.Am J Health Syst Pharm.2017.74(9).e183-e192.SCI |
| 53. Bi J, Li X, Liu J, Chen D, Li S, Hou J, Zhou Y, Zhu S, Zhao Z, Qin E, Wei Z..Population pharmacokinetics of peginterferon α2a in patients with chronic.Sci Rep.2017.11;7(1).7893.SCI |
| 54. Li X, Zhao K, Ma N, Sun S, Miao Z, Zhao Z.Association of ABCB1 promoter methylation with aspirin exposure, platelet function, and clinical outcomes in.Eur J Clin Pharmacol.2017.73(10).1261-1269.SCI |
| 55. Li X,Sun S,Ling X1,Chen K4,Wang Q,Zhao Z*.Plasma and cerebrospinal fluid population pharmacokinetics of vancomycin in postoperative neurosurgical patients after combined intravenous and intraventricular administration.Eur J Clin Pharmacol.2017.73(12).1599-1607.SCI |
| 56. Wang Q,Sun S,Xie M,Zhao K,Li X,Zhao Z*.Association between the HLA-B alleles and carbamazepine-induced SJS/TEN: A meta-analysis.Epilepsy Res.2017.135.19-28.SCI |
| 57. Li X,Mei S,Gong X,Zhou H,Yang L,Zhou A,Liu Y,Li X,Zhao Z,Zhang X.Relationship between Azathioprine metabolites and therapeutic efficacy in Chinese patients with neuromyelitis optica spectrum disorders.BMC Neurol.2017.17(1).130.SCI |
| 58. Mei S, Luo X, Li X, Li Q, Huo J, Yang L, Zhu L, Feng W, Zhou J, Shi G, Zhao Z..Development and validation of an LC-MS/MS method for the determination of tigecycline in human plasma and cerebrospinal fluid and its application to a pharmacokinetic study..Biomed Chromatogr.2016.30(12).1992-2002.SCI |
| 59. Zhu B, Zhang L, Zhang YY, Wang L, Li XG, Liu T, Fu YK, Zheng YF, Li P, Zhao ZG..DNase I aggravates islet β-cell apoptosis in type 2 diabetes..Mol Med Rep.2016.13(6).4577-84.SCI |
| 60. Li X, Chen Y, Zhao Z, Lu W, Zhou T..Pharmacokinetic/Pharmacodynamic Analysis of Metformin using Different Models in Diabetic Rats..Drug Res (Stuttg)..2016.66(10).547-554.SCI |
| 61. Li XQ, Ma N, Li XG, Wang B, Sun SS, Gao F, Mo DP, Song LG, Sun X, Liu L, Zhao XQ, Wang YL, Wang YJ, Zhao ZG, Miao ZR..Association of PON1,P2Y12 and COX1 with Recurrent Ischemic Events in Patient with Extracranial or Intracranial Stenting.PLOS One.2016.11(2).e0148891.SCI |
| 62. Li XG, Ma N, Wang B, Li XQ, Mei SH, Zhao K, Wang YJ, Li W, Zhao ZG, Sun SS, Miao ZR..The impact of P2Y12 promoter DNA methylation on the recurrence of ischemic events in Chinese patients with ischemic cerebrovascular disease.Sci Rep..2016.6.34570.SCI |
| 63. Zhao Z, Li X, Sun S, Mei S, Ma N, Miao Z, Zhao M, Peng S..Impact of genetic polymorphisms related to clopidogrel or acetylsalicylic acid pharmacology on clinical outcome in Chinese patients with symptomatic extracranial or intracranial stenosis..Eur J Clin Pharmacol.2016.72(10).1195-204.SCI |
| 64. Li X, Wu Y, Sun S, Zhao Z, Wang Q..Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients and the Application in Dosing Recommendation..J Pharm Sci.2016.105(11).3425-3431.SCI |
| 65. B Zhu, L Zhang, YY Fan, L Wang, XG Li, T Liu, YS Cao, ZG Zhao..Metformin versus insulin in gestational diabetes mellitus：a meta-analysis of randomized clinical trials..Ir J Med Sci. .2016.185(2).371-81.SCI |
| 66. Li X, Wu Y, Sun S, Mei S, Wang J, Wang Q, Zhao Z.Population pharmacokinetics of vancomycin in postoperative neurosurgical patients.Journal of pharmaceutical Sciences.2015.104（11）.3960-7.SCI |
| 67. Zhu B, Zheng YF, Zhang YY, Cao YS, Zhang L, Li XG, Liu T, Jiao ZZ, Wang Q, Zhao ZG.The protecting effect of L-carnitine in Cyclophosphamide induced Germ Cell Apoptosis.J Zhejiang Univ Sci B.2015.16（9）.780-7.SCI |
| 68. Wang B, Li XQ, Ma N, Mo D, Gao F, Sun X, Xu X, Liu L, Song L, Li XG, Zhao Z, Zhao X, Miao ZR.Association of thrombelastographic parameters with post-stenting ischemic events.J NeuroIntervent Surg.2015.pii.neurintsurg-2015-011687.SCI |
| 69. Chen K, Wu Y, Wang Q, Wang J, Li X, Zhao Z, Zhou J.The methodology and pharmacokinetics study of intraventricular administration of vancomycin in patients with intracranial infections after craniotomy.JOURNAL OF CRITICAL CARE.2015.30.218e1-e5.SCI |
| 70. 李新刚,卢炜,周田彦,赵志刚*.常用药动学/药效学分析软件与评价.中国药房.2014.25（37）.3541-3543.核心期刊 |
| 71. 史卫忠,王莉文,赵志刚*.北京二级医院与社区医院2009-2012年药品销售情况比较分析.中国药房.2014.25（22）.2022-2025.核心期刊 |
| 72. 黄佳,梅升辉,赵志刚*.糖尿病患者国内外药学服务模式探讨.中国药学杂志.2014.49（11）.951-954.核心期刊 |
| 73. 李新刚,刘振华,田德蔷,史卫忠,余克富,霍记平,赵志刚*.个体化给药研究的文献分析.中国药房.2014.25（38）.3635-3639.核心期刊 |
| 74. 李新刚,赵志刚*.我国临床药学的发展机遇与挑战.中国药房.2014.25（5）.385-387.核心期刊 |
| 75. 李新刚,赵志刚*.药物在中心室平均滞留时间的计算方法.中国药学杂志.2014.49（15）.1364-1368.核心期刊 |
| 76. 曹凯风,王莉文,赵志刚*.北京市71家基层医疗机构2010-2012年HMG-CoA还原酶抑制剂应用情况分析.药学服务与研究.2014.14（4）.283-285.核心期刊 |
| 77. 赵伟杰,郑梅琴,王彬,付雷,李芃,赵志刚*.IFN-γ和IL-10作为药物抗结核活性评价指标的可行性考察.中国药学杂志.2014.49（9）.759-763.核心期刊 |
| 78. 付晓秀,胡爱君,刘腾,赵志刚*.ERCP术后急性胰腺炎患者的药学监护.中国现代应用药学.2014.（1）.112-115.核心期刊 |
| 79. 田德蔷，赵志刚*.门诊干部药房库存药品上下限设定集影响因素.实用药物与临床.2013.16（7）.657-658.核心期刊 |
| 80. 白彩珍，赵志刚*.认真做好医学伦理委员会委员聘选工作.医药导报.2013.32（3）.405-407.核心期刊 |
| 81. 韩建，王莉文，赵志刚*.北京地区70家基层医疗机构2010-2012年心脏治疗药使用情况分析.中国医药导报.2013.10（27）.112-117.核心期刊 |
| 82. 李新刚，赵志刚*.基于机制的药动学/药效动力学模型介绍.中国新药杂志.2013.22（10）.1180-1185.核心期刊 |
| 83. 朱月亭，徐蓓，赵志刚*.北京地区34家三级甲等医院2009-2012年抗癫痫药利用分析.中国药房.2013.24（38）.3571-3574.核心期刊 |
| 84. 刘胜男，赵志刚*.心血管药物基因组学的研究进展.中国临床药理学杂志.2013.29（3）.225-227.核心期刊 |
| 85. 李新刚，赵志刚*.群体药代动力学研究进展.中国临床药理学杂志.2013.29（1）.73-75.核心期刊 |
| 86. 刘胜男，王佳庆，梅升辉，赵志刚*.HPLC法测定人血浆中万古霉素浓度及其药动学研究.实用药物与临床.2013.16（5）.426-428.核心期刊 |
| 87. Xiangli Cui, Zhiqin Xu, Zhigang Zhao, Dali Sui, Xiaohui Ren, Qiming Huang, Jiazhen Qin, Limin Hao, Zhenguang Wang, Li Shen, Song Lin*.Analysis of CD137L and IL-17 Expression in tumor tissue as Prognostic Indicators for Gliblastoma..Int J Biological science.2013.9(2).134-141.SCI |
| 88. 徐蓓，赵志刚*.治疗黄斑疾病的新型血管内皮生长因子抑制剂阿柏西普.中国新药杂志.2013.22（6）.617-619.核心期刊 |
| 89. 黄宇，王莉文，赵志刚*.2002~2010年北京天坛医院颅内恶性肿瘤住院患者用药分析.中国医院用药评价与分析.2012.12（2）.139-141.核心期刊 |
| 90. 刘宪军，赵志刚*.北京市社区医疗卫生机构实施集中处方点评效果分析.中国医院用药评价与分析.2012.12（4）.370-372.核心期刊 |
| 91. 黄宇，赵志刚*，王莉文.2011年北京地区69家社区医院调节血脂药应用分析.中国医院用药评价与分析.2012.12（7）.610-612.核心期刊 |
| 92. 崔向丽，林松，史卫忠，赵志刚*.临床药师参与神经外科药物治疗实践.中国药学杂志.2012.47(19).1600-1603.核心期刊 |
| 93. 崔向丽，隋大立，李靖，张宇，史卫忠，赵志刚* .高渗药物使用风险与规避.中国药物警戒.2012.9（10）.628-630.核心期刊 |
| 94. Gui-shan Jin, Gui-dong Zhu, Zhi-gang，Fu-sheng Liu*.VP22 enhances the expression of glucocerebrosidase in human Gaucher II fibroblast cells mediated by lentiviral vector.clinical and experimental medicine.2012.12（3）.135-143.SCI |
| 95. 崔向丽,林松,史卫忠,赵志刚*. 临床药师参与神经外科药物治疗实践.中国药学杂志.2012.（19）.1600-1603.核心期刊 |
| 96. 何应军,王芳,刘腾,赵志刚*.对1例肝细胞性黄疸患者的药学监护.中国当代医药.2012.（28）.153-154.核心期刊 |
| 97. 刘胜男,赵志刚*.血小板P2Y_(12)受体拮抗剂临床研究进展.中国新药杂志.2012.（11）.1241-1246.核心期刊 |
| 98. Jin GS, Zhu GD, Zhao ZG, Liu FS.VP22 enhances the expression of glucocerebrosidase in human Gaucher II fibroblast cells mediated by lentiviral vectors.CLINICAL AND EXPERIMENTAL MEDICINE.2012.12.135-143.SCI |
| 99. 徐蓓，赵志刚*.脑血管病治疗药物丁苯酞注射液的药理与临床评价研究.中国新药杂志.2011.20（11）.947-950.核心期刊 |
| 100. 吴浩，常利杰，赵志刚*.国家基本药物制度的实施对社区用药情况的影响研究.中国全科医学.2011.14（5）.1425-1427.核心期刊 |
| 101. 海沙尔江.吾守尔，赵志刚*，史录文.我国药学技术人员对收取药事服务费的认知情况调查分析.中国药房.2011.22（24）.2222-2224.核心期刊 |
| 102. 鲁秀玲，赵志刚*.北京市社区卫生服务中心“零差率”药品政策的实施与思考.中国药房.2011.22（48）.4596~4599.核心期刊 |
| 103. 王莉文，赵志刚*.2007~2009年北京地区注射用抗菌药物给药频度的PK/PD模型分析.中国医院用药评价与分析.2011.11（6）.502-503.核心期刊 |
| 104. 鲁秀玲，赵志刚*.222例氟喹诺酮类抗菌药物致不良反应报告分析.中国医院用药评价与分析.2011.11（6）.563-565.核心期刊 |
| 105. 鲁秀玲，高玉梅，赵志刚*.2007~2009年北京市朝阳区社区卫生服务中心“零差率”抗高血压要使用情况分析.中国药房.2011.21（40）.3810-3812.核心期刊 |
| 106. 任夏洋，赵志刚*.抗癫痫药的药物基因组学研究进展.《中国临床药理学杂志》.2010.26（5）.386-390.核心期刊 |
| 107. 李忠东，刘敏，赵志刚*.临床药师建立“三种思维”的体会.《药学服务与研究》.2010.10（5）.321-323.核心期刊 |
| 108. 常利杰，赵志刚*，王莉文.2009年1-3月北京市城区31家社区卫生服务机构抗高血压药应用分析.《中国医院用药评价与分析》.2009.9（11）.814-816.核心期刊 |
| 109. 赵志刚，朱珠，孙路路，韩容.医院药学60年回顾与展望.《中国药学杂志》.2009.44（19）.1463-1469.核心期刊 |
| 110. 司延斌，赵志刚*.对全国部分地区医疗机构头孢类抗菌药物皮肤过敏试验的调查与分析.《中国临床药理学杂志》.2009.25(2）.161-166.核心期刊 |
| 111. 杨丽英，赵志刚.高校医院开展药学服务之探讨.《中国药房》.2009.20（8）.636-638.核心期刊 |
| 112. 黄佳,史卫忠,邢轶华,于玥,金丽,孙毅,李皓,王晓宇,张勇,王宁,赵志刚*.6种常用中药注射剂与不同厂家输液配伍的不溶性微粒变化.《吉林中医药》.2009.29（8）.715-716.核心期刊 |
| 113. 王莉文.张立仁.杨科.朱传钧.张婕.陈慧英.赵志刚*.北京天坛医院实施限制药品收入比例措施的效果与协调办法探讨.《药学服务与研究》.2009.9（6）.410-413.核心期刊 |
| 114. 黄佳，李婷，史卫忠，赵志刚*.高效液相色谱法测定家兔血浆中红景天苷浓度及其药代动力学研究.《吉林中医药》.2009.29（11）.989-991.核心期刊 |
| 115. 赵志刚,王莉文,朱乐婷,朱传钧.全国5地区16家医院药品短缺现象分析.《药学服务与研究》.2008.8（4）.246-248.核心期刊 |
| 116. 袁锁中，赵志刚*.关于我国临床药学的思考.《药学服务与研究》.2008.8（3）.166-170.核心期刊 |
| 117. 赵志刚.抗痛风药的合理应用.《中国医刊》.2008.43（7）.17-18.核心期刊 |
| 118. 赵志刚.我院药剂科发展的战略管理与思考.《中国医院药学杂志》.2006.26（7）.870-872.核心期刊 |
| 119. 赵志刚，李嘉静，杨莉，赵秀丽，王淑民，李冬梅，孙运强.盐酸二甲双胍缓释胶囊在健康人体的生物等效性研究.《中国药学杂志》.2006.41(20).1579-1582.核心期刊 |
